読み込み中
iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically embodied in products like the Zio XT and AT monitors—with a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Verily Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.
前日終値
$106.7
+$4.10 · +4.00%
日中の時刻はETです。市場データは遅延する場合があります。
iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically embodied in products like the Zio XT and AT monitors—with a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Verily Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.
日中レンジ
現在 $106.7
52週レンジ
現在 $106.7
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
78
割安
センチメント
66
強気
リスク
59
やや高いリスク
モメンタム
34
弱含み
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically embodied in products like the Zio XT and AT monitors—with a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Verily Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.
日中レンジ
現在 $106.7
52週レンジ
現在 $106.7
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 7.47億 USD | 5.92億 USD | 4.93億 USD | 4.11億 USD | 3.23億 USD |
| 売上原価 | 2.2億 USD | 1.84億 USD | 1.61億 USD | 1.29億 USD | 1.09億 USD |
| 粗利益 | 5.27億 USD | 4.08億 USD | 3.32億 USD | 2.82億 USD | 2.14億 USD |
| 研究開発 | 8461万 USD | 1.04億 USD | 6024.4万 USD | 4661万 USD | 3867.1万 USD |
| 販売・一般管理 | 4.79億 USD | 4.19億 USD | 3.86億 USD | 3.22億 USD | 2.75億 USD |
| 営業費用 | 5.64億 USD | 5.23億 USD | 4.57億 USD | 3.95億 USD | 3.14億 USD |
| 受取利息 | 2152.1万 USD | 2193.8万 USD | 615.5万 USD | 235万 USD | 11.8万 USD |
| 支払利息 | 1315.4万 USD | 1282.1万 USD | 365万 USD | 413.8万 USD | 116.9万 USD |
| 減価償却費と償却費 | 2647.9万 USD | 2577.7万 USD | 2214.4万 USD | 1960.9万 USD | 1659.4万 USD |
| 営業利益 | −3681万 USD | −1.16億 USD | −1.25億 USD | −1.14億 USD | −9994.3万 USD |
| 純利益 | −4455.1万 USD | −1.13億 USD | −1.23億 USD | −1.16億 USD | −1.01億 USD |
会社概要が更新されました 2026年10月12日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$174.88
上昇余地（63.90%）価格履歴は利用できません
最高：$196平均：$174.88最低：$160この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI1.22億0.01%2.3兆 USD0.03%$381.94+0.63%
iShares Russell 2000 ETFIWM8919.23万0.11%787.4億 USD0.19%$278.94+0.49%
Vanguard Morningstar Small-Cap ETFVB8844.85万0.05%1853億 USD0.03%$289.48+0.64%
Vanguard Morningstar Small-Cap Growth ETFVBK5084.83万0.11%447億 USD0.05%$344.74+1.22%
Vanguard Extended Market ETFVXF4544.95万0.05%954億 USD0.05%$235+0.80%
iShares Russell 2000 Growth ETFIWO3137.42万0.23%139.17億 USD0.24%$356.78+0.94%
Vanguard Russell 2000 ETFVTWO2264.51万0.12%180億 USD0.06%$112.66+0.50%
Schwab U.S. Small-Cap ETFSCHA1789.73万0.08%218.24億 USD0.03%$32.79+0.40%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Growth ETFVBKVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWOSchwab U.S. Small-Cap ETFSCHAAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
